Cargando…

Transcriptomic and proteomic assessment of tocilizumab response in a randomized controlled trial of patients hospitalized with COVID-19

High interleukin (IL)-6 levels are associated with greater COVID-19 severity. IL-6 receptor blockade by tocilizumab (anti-IL6R; Actemra) is used globally for the treatment of severe COVID-19, yet a molecular understanding of the therapeutic benefit remains unclear. We characterized the immune profil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shivram, Haridha, Hackney, Jason A., Rosenberger, Carrie M., Teterina, Anastasia, Qamra, Aditi, Onabajo, Olusegun, McBride, Jacqueline, Cai, Fang, Bao, Min, Tsai, Larry, Regev, Aviv, Rosas, Ivan O., Bauer, Rebecca N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470387/ https://www.ncbi.nlm.nih.gov/pubmed/37664617 http://dx.doi.org/10.1016/j.isci.2023.107597

Ejemplares similares

Prognostic value of severe acute respiratory syndrome coronavirus‐2 viral load and antibodies in patients hospitalized with COVID‐19
por: Bauer, Rebecca N., et al.
Publicado: (2023)

Prognostic and Predictive Biomarkers in Patients With Coronavirus Disease 2019 Treated With Tocilizumab in a Randomized Controlled Trial*
por: Tom, Jennifer, et al.
Publicado: (2021)

A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signaling
por: Hackney, Jason A., et al.
Publicado: (2023)

Identification and removal of sequencing artifacts produced by mispriming during reverse transcription in multiple RNA-seq technologies
por: Shivram, Haridha, et al.
Publicado: (2018)

Chd1 co-localizes with early transcription elongation factors independently of H3K36 methylation and releases stalled RNA polymerase II at introns
por: Park, Daechan, et al.
Publicado: (2014)

MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network
por: Shivram, Haridha, et al.
Publicado: (2019)

PRC2 activates interferon-stimulated genes indirectly by repressing miRNAs in glioblastoma
por: Shivram, Haridha, et al.
Publicado: (2019)

Diverse ATPase Proteins in Mobilomes Constitute a Large Potential Sink for Prokaryotic Host ATP
por: Shim, Hyunjin, et al.
Publicado: (2021)

IgG Immune Complexes Inhibit Naïve T Cell Proliferation and Suppress Effector Function in Cytotoxic T Cells
por: Charab, Wissam, et al.
Publicado: (2021)

Gut Microbiome Homeostasis and the CD4 T- Follicular Helper Cell IgA Axis in Human Immunodeficiency Virus Infection
por: Onabajo, Olusegun O., et al.
Publicado: (2021)

Potent CRISPR-Cas9 inhibitors from Staphylococcus genomes
por: Watters, Kyle E., et al.
Publicado: (2020)

Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
por: Rosas, Ivan O., et al.
Publicado: (2021)

Chronic simian immunodeficiency virus infection is associated with contrasting phenotypes of dysfunctional Bcl6(+) germinal center B cells or Bcl6(−)Bcl2(+) non‐germinal center B cells
por: Onabajo, Olusegun O., et al.
Publicado: (2018)

Comparative Functional Analysis of 12 Mammalian IFN-λ4 Orthologs
por: Paquin, Ashley, et al.
Publicado: (2016)

Early Amplified Respiratory Bioactive Lipid Response Is Associated With Worse Outcomes in Pediatric Influenza-Related Respiratory Failure
por: Anania, Veronica G, et al.
Publicado: (2020)

Rhesus Macaque Lymph Node PD-1(hi)CD4(+) T Cells Express High Levels of CXCR5 and IL-21 and Display a CCR7(lo)ICOS(+)Bcl6(+) T-Follicular Helper (Tfh) Cell Phenotype
por: Onabajo, Olusegun O., et al.
Publicado: (2013)

A Protein Antagonist of Activation-Induced Cytidine Deaminase Encoded by a Complex Mouse Retrovirus
por: Singh, Gurvani B., et al.
Publicado: (2019)

Interleukin-6 inhibition for treatment of rheumatoid arthritis: A review of tocilizumab therapy
por: Patel, Aarat M, et al.
Publicado: (2010)

Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial
por: Rosas, Ivan O., et al.
Publicado: (2021)

Impact of tocilizumab administration on mortality in severe COVID-19
por: Tsai, Andrew, et al.
Publicado: (2020)

Tocilizumab and COVID-19
por: Chaudhry, Dhruva, et al.
Publicado: (2020)

Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA)
por: Burmester, Gerd R, et al.
Publicado: (2016)

Subcutaneous Tocilizumab May Be Effective in Refractory Fibromyalgia Patients
por: Tang, Kuo-Tung, et al.
Publicado: (2023)

ISMB 2003 BioPathways SIG and 5th BioPathways Meeting
por: Schachter, Vincent, et al.
Publicado: (2003)

BRNI: Modular analysis of transcriptional regulatory programs
por: Nachman, Iftach, et al.
Publicado: (2009)

The network effect: studying COVID-19 pathology with the Human Cell Atlas
por: Teichmann, Sarah, et al.
Publicado: (2020)

Deep generative model embedding of single-cell RNA-Seq profiles on hyperspheres and hyperbolic spaces
por: Ding, Jiarui, et al.
Publicado: (2021)

Efficacy of tocilizumab treatment in severely ill COVID-19 patients
por: Zhao, Jie, et al.
Publicado: (2020)

Efficacy of the early treatment with tocilizumab-hydroxychloroquine and tocilizumab-remdesivir in severe COVID-19 Patients
por: Sarhan, Rania M., et al.
Publicado: (2022)

Serum Proteome Analysis in Patients with Rheumatoid Arthritis Receiving Therapy with Tocilizumab: An Anti-Interleukin-6 Receptor Antibody
por: Yanagida, Mitsuaki, et al.
Publicado: (2013)

Chromosome-Level Assembly of the Caenorhabditis remanei Genome Reveals Conserved Patterns of Nematode Genome Organization
por: Teterina, Anastasia A., et al.
Publicado: (2020)

DIALOGUE maps multicellular programs in tissue from single-cell or spatial transcriptomics data
por: Jerby-Arnon, Livnat, et al.
Publicado: (2022)

Tocilizumab: Neutropenia: case report
Publicado: (2020)

Günstige Effekte von Tocilizumab
por: Diener, Hans-Christoph
Publicado: (2020)

Papulopustular Rash Due to Tocilizumab
por: Kohro-Kawata, Junko, et al.
Publicado: (2019)

Tocilizumab in severe COVID-19
por: Lucio Liberato, Nicola, et al.
Publicado: (2020)

Tocilizumab ohne überzeugende Wirkung
por: Diener, Hans-Christoph
Publicado: (2021)

Cases of pancreatitis reported with tocilizumab
Publicado: (2021)

Time for tocilizumab in COVID-19?
por: Butler, Ethan, et al.
Publicado: (2021)

Tocilizumab: Neutropenia: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_skvh6sqamlrdmcos51ouhsc80i